Reciprocal regulation of osteocalcin transcription by the homeodomain proteins msx2 and dlx5

被引:121
|
作者
Newberry, EP
Latifi, T
Towler, DA
机构
[1] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Ctr Cardiovasc Red,Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, Ctr Cardiovasc Red,Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
关键词
D O I
10.1021/bi981878u
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteocalcin(OC) is a small calcium binding protein expressed in bones and teeth undergoing mineralization. OC expression in calvarial osteoblasts and odontoblasts is regulated in part via protein-protein interactions between the homeodomain repressor, Msx2, and components of the cell type-specific basal OC promoter. Recent work suggests that homeodomain proteins form heterodimers that confer transcriptional regulation. Since the homeodomain proteins D1x5 and Msx2 are both expressed by primary rat calvarial osteoblasts, we examined whether Msx2 and D1x5 functionally interact to regulate the OC promoter. In both primary rat calvarial and MC3T3E1 mouse calvarial osteoblasts, transient expression of D1x5 only mildly augments basal OC promoter (luciferase reporter) activity, while Msx2 suppresses transcriptional activity by ca. 80%. However, D1x5 completely reverses Msx2 repression of the OC promoter. Structure-function analyses using far-Western blot and transient cotransfection assays reveal that (i) Msx2 and D1x5 can form dimers, (ii) D1x5 residues 127-143 are necessary for dimerization and to reverse Msx2-dependent OC repression, and (iii) intrinsic DNA binding activity of D1x5 is not required for OC regulation. Msx2 inhibits the DNA binding activity of a third complex, the OC fibroblast growth factor response element binding protein (OCFREB), that supports activity of the basal OC promoter. D1x5 completely abrogates Msx2 suppression of OCFREB DNA binding activity, and residues required for D1x5 transcriptional de-repression in vivo are also required for reversing inhibition of OCFREB binding in vitro. Finally, D1x5 reverses Msx2 inhibition of OC promoter activation by FGF2/forskolin. Thus, D1x5 regulates the expression of the OC promoter in calvarial osteoblasts in part by de-repression, antagonizing Msx2 repression of transcription factors that support basal OC promoter activity.
引用
收藏
页码:16360 / 16368
页数:9
相关论文
共 50 条
  • [21] Msx1 and Dlx5 Function Synergistically to Regulate Frontal Bone Development
    Chung, Il-Hyuk
    Han, Jun
    Iwata, Junichi
    Chai, Yang
    [J]. GENESIS, 2010, 48 (11) : 645 - 655
  • [22] Stimulus-selective inhibition of rat osteocalcin promoter induction and protein-DNA interactions by the homeodomain repressor Msx2
    Newberry, EP
    Boudreaux, JM
    Towler, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) : 29607 - 29613
  • [23] 健骨颗粒对去卵巢小鼠miR-141及成骨基因Dlx5/Msx2/Runx2的影响
    张志恒
    张文明
    魏振朴
    张楚天
    杨娟
    林燕萍
    [J]. 康复学报, 2018, 28 (06) : 26 - 31
  • [24] Inhibition of STAT5A promotes osteogenesis by DLX5 regulation
    Lee, Kyoung-Mi
    Park, Kwang Hwan
    Hwang, Ji Suk
    Lee, Moses
    Yoon, Dong Suk
    Ryu, Hyun Aae
    Jung, Ho Sun
    Park, Ki Won
    Kim, Jihyun
    Park, Sahng Wook
    Kim, Sung-Hwan
    Chun, Yong-Min
    Choi, Woo Jin
    Lee, Jin Woo
    [J]. CELL DEATH & DISEASE, 2018, 9
  • [25] Regulation of osteoblast differentiation by Dlx5 in transgenic mice.
    Chin, H
    Li, H
    Wang, CL
    Lichtler, AC
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S47 - S47
  • [26] Msx1 and Dlx5 act independently in development of craniofacial skeleton, but converge on the regulation of Bmp signaling in palate formation
    Levi, G
    Mantero, S
    Barbieri, O
    Cantatore, D
    Paleari, L
    Beverdam, A
    Genova, F
    Robert, B
    Merlo, GR
    [J]. MECHANISMS OF DEVELOPMENT, 2006, 123 (01) : 3 - 16
  • [27] A MUTATION IN THE HOMEODOMAIN OF THE MSX2 GENE IN A FAMILY AFFECTED WITH CRANIOSYNOSTOSIS, BOSTON TYPE
    LI, X
    MA, L
    SNEAD, M
    HAWORTH, I
    SPARKES, R
    JACKSON, C
    WARMAN, M
    MULLIKEN, J
    MAXSON, R
    MULLER, U
    JABS, E
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 213 - 213
  • [28] Inhibition of STAT5A promotes osteogenesis by DLX5 regulation
    Kyoung-Mi Lee
    Kwang Hwan Park
    Ji Suk Hwang
    Moses Lee
    Dong Suk Yoon
    Hyun Aae Ryu
    Ho Sun Jung
    Ki Won Park
    Jihyun Kim
    Sahng Wook Park
    Sung-Hwan Kim
    Yong-Min Chun
    Woo Jin Choi
    Jin Woo Lee
    [J]. Cell Death & Disease, 9
  • [29] Transcription Factor DLX5 As a New Target for Promising Antitumor Agents
    Timakhov, R. A.
    Fedichev, P. O.
    Vinnik, A. A.
    Testa, J. R.
    Favorova, O. O.
    [J]. ACTA NATURAE, 2011, 3 (03): : 47 - 51
  • [30] Smad1 binding to the Dlx5 promoter is responsible for the BMP-2 induced Dlx5 expression
    Park, H
    Kim, Y
    Kim, B
    Shin, H
    Cho, J
    Ryoo, H
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S75 - S75